Valsartan and cancer, liver damage

November 13, 2019
Category: Legal

Valsartan is an angiotensin-receptor blocker which is prescribed to patients with high blood pressure or congestive heart failure. Valsartan is widely manufactured overseas. Unfortunately, the Food and Drug Administration (FDA) has found Valsartan drugs made by generic manufacturers to be contaminated with N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA). These impurities may have the potential to cause cancer and/or serious liver damage, which has prompted widespread recalls published by the FDA.

Recent lawsuits claim that Valsartan drugs may have been tainted with potentially cancer causing impurities as far back as 2012. Not all Valsartan drugs are tainted or contaminated. Patients being treated with possibly tainted Valsartan medications should have received notice in or around July 2018, regarding whether the lots of Valsartan drugs involved in their treatment were involved in the pending recalls.

If you took contaminated Valsartan and suffer from liver cancer, liver damage, colorectal cancer, kidney cancer, kidney damage, or gastric cancer, the drug company may be liable for your injury. Fill out the form below, and an attorney will assess your case.

 

Leave a Reply

Your email address will not be published. Required fields are marked *